Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Vion awarded SBIR grant to support development of sulfonyl hydrazine prodrugs

July 17, 2001

Significant clinical antileukemic activity demonstrated for signal transduction inhibitor

July 17, 2001

Aventis licenses new solid tumor treatment from Ajinomoto

July 17, 2001

Antisoma enters supply agreement for thioplatin

July 17, 2001

Nontoxic MMP inhibitor from Pharmacia with antitumor activity

July 16, 2001

Exelixis delivers cancer antibody targets to PDL for further development

July 16, 2001

Neutrophil elastase inhibitor prevents cancer metastasis in animal model

July 16, 2001

Idec submits additional information for Zevalin BLA

July 16, 2001

New Photofrin indication filed with Canadian authorities

July 16, 2001

Tie2 receptor kinase inhibitors useful for angiogenic disorders

July 13, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...